由于2025年11月26日股价上升,PTC 治疗内幕人士在收入丰厚后出售了数百万股票。 PTC Therapeutics insiders sold millions in stock after strong earnings, as shares rose on November 26, 2025.

2025年11月25日, PTC 治疗内幕者Neil Gregory Almstead和Allan Steven Jacobson出售了大股,Almstead卸下71 928股,价值83.44美元,Jacobson出售14 199股,价值83.55美元,筹集数百万美元。 On November 25, 2025, PTC Therapeutics insiders Neil Gregory Almstead and Allan Steven Jacobson sold significant shares, with Almstead offloading 71,928 shares at $83.44 and Jacobson selling 14,199 shares at $83.55, raising millions. 这些交易是在11月4日报告Q3收入丰厚之后进行的,显示EPS为20美元,收入为2.1101亿美元,两者均超过预期。 These transactions followed strong Q3 earnings reported on November 4, which showed $0.20 EPS and $211.01 million in revenue, both exceeding expectations. 11月26日,库存升至86.25美元,增加3.32美元,交易量增加。 The stock rose to $86.25 on November 26, up $3.32, with elevated trading volume. 尽管预计2025财政年度的EPS为负负值,但分析师仍保持“机动购买”评级,目标价格为75.40美元。 Despite a projected negative EPS for fiscal 2025, analysts maintain a "Moderate Buy" rating with a target price of $75.40.